Skip to main content
Top
Gepubliceerd in:

01-06-2011

Patterns of reporting health-related quality of life outcomes in randomized clinical trials: implications for clinicians and quality of life researchers

Auteurs: Michael Brundage, Brenda Bass, Judith Davidson, John Queenan, Andrea Bezjak, Jolie Ringash, Anna Wilkinson, Deb Feldman-Stewart

Gepubliceerd in: Quality of Life Research | Uitgave 5/2011

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Abstract

Purpose

To assess the patterns of, and trends over time in, health-related quality of life (HRQL) reporting in randomized controlled trials (RCTs).

Methods

The English-language literature of RCTs published in 2002–2008 was identified using Medline, Embase, and Healthstar databases, in addition to the Cochrane Clinical Trials Registry. Eligible trials were phase III studies that included an HRQL outcome. Data were abstracted on eight outcomes derived from previously recommended quality standards for reporting HRQL, and on four outcomes describing how HRQL data are presented in RCT reports. Two readers examined each article; discrepancies were resolved through discussion and third review if required.

Results

A sample of 794 RCTs was identified. HRQL was a primary outcome in 25.4% (200/794). One hundred and ten RCTs (14%) used “supplementary” reports (separate from the first publication) to report HRQL findings. The proportion of RCTs that met the eight quality indicators ranged from 15% (HRQL used in the calculation of sample size) to 81% (reporting instrument validity). RCTs with HRQL as a primary outcome or with a supplementary report had higher concordance on the quality measures. Reporting improved on many indicators over time. Substantive variation in how HRQL data are presented in RCTs was evident.

Conclusions

Current practice of reporting HRQL outcomes in RCTs remains highly variable, both with regard to quality of reporting and the patterns of data analysis and presentation. This variation presents challenges for clinicians to apply these data in clinical practice. Consistent reporting practices, which are interpretable by clinicians, are required, as are processes to achieve this consistency in future reports.
Literatuur
1.
go back to reference Karnofsky, D. A., Abelmann, W. H., Craver, L. F., & Burchenal, J. H. (1948). The use of nitrogen mustards in the palliative treatment of carcinoma. Cancer, 1, 634–656.CrossRef Karnofsky, D. A., Abelmann, W. H., Craver, L. F., & Burchenal, J. H. (1948). The use of nitrogen mustards in the palliative treatment of carcinoma. Cancer, 1, 634–656.CrossRef
2.
go back to reference Steinbrocker, O., Traeger, C. H., & Batterman, R. C. (1949). Therapeutic criteria in rheumatoid arthritis. JAMA, 140(8), 659–662. Steinbrocker, O., Traeger, C. H., & Batterman, R. C. (1949). Therapeutic criteria in rheumatoid arthritis. JAMA, 140(8), 659–662.
3.
go back to reference Bowling, A. (1995). Measuring disease: A review of disease-specific quality of life measurement scales. Buckingham: Open University Press. Bowling, A. (1995). Measuring disease: A review of disease-specific quality of life measurement scales. Buckingham: Open University Press.
4.
go back to reference Ellwood, P. M. (1988). Shattuck lecture-outcomes management. A technology of patient experience. New England Journal of Medicine, 318(23), 1549–1556.PubMedCrossRef Ellwood, P. M. (1988). Shattuck lecture-outcomes management. A technology of patient experience. New England Journal of Medicine, 318(23), 1549–1556.PubMedCrossRef
5.
go back to reference Oxman, A. D., Sackett, D. L., & Guyatt, G. H. (1993). Users’ guides to the medical literature. I. How to get started. The Evidence-Based Medicine Working Group. Journal of the American Medical Association, 270(17), 2093–2095.PubMedCrossRef Oxman, A. D., Sackett, D. L., & Guyatt, G. H. (1993). Users’ guides to the medical literature. I. How to get started. The Evidence-Based Medicine Working Group. Journal of the American Medical Association, 270(17), 2093–2095.PubMedCrossRef
6.
go back to reference Staquet, M., Berzon, R., Osoba, D., & Machin, D. (1996). Guidelines for reporting results of quality of life assessments in clinical trials. Quality of Life Research, 5(5), 496–502.PubMedCrossRef Staquet, M., Berzon, R., Osoba, D., & Machin, D. (1996). Guidelines for reporting results of quality of life assessments in clinical trials. Quality of Life Research, 5(5), 496–502.PubMedCrossRef
7.
go back to reference Lee, C. W., & Chi, K. N. (2000). The standard of reporting of health-related quality of life in clinical cancer trials. Journal of Clinical Epidemiology, 53(5), 451–458.PubMedCrossRef Lee, C. W., & Chi, K. N. (2000). The standard of reporting of health-related quality of life in clinical cancer trials. Journal of Clinical Epidemiology, 53(5), 451–458.PubMedCrossRef
8.
go back to reference Efficace, F., Bottomley, A., & van Andel, G. (2003). Health related quality of life in prostate carcinoma patients: A systematic review of randomized controlled trials. Cancer, 97(2), 377–388.PubMedCrossRef Efficace, F., Bottomley, A., & van Andel, G. (2003). Health related quality of life in prostate carcinoma patients: A systematic review of randomized controlled trials. Cancer, 97(2), 377–388.PubMedCrossRef
9.
go back to reference Efficace, F., Bottomley, A., Osoba, D., et al. (2003). Beyond the development of health-related quality-of-life (HRQOL) measures: A checklist for evaluating HRQOL outcomes in cancer clinical trials–does HRQOL evaluation in prostate cancer research inform clinical decision making? Journal of Clinical Oncology, 21(18), 3502–3511.PubMedCrossRef Efficace, F., Bottomley, A., Osoba, D., et al. (2003). Beyond the development of health-related quality-of-life (HRQOL) measures: A checklist for evaluating HRQOL outcomes in cancer clinical trials–does HRQOL evaluation in prostate cancer research inform clinical decision making? Journal of Clinical Oncology, 21(18), 3502–3511.PubMedCrossRef
10.
go back to reference Efficace, F., Osoba, D., Gotay, C., Sprangers, M., Coens, C., & Bottomley, A. (2007). Has the quality of health-related quality of life reporting in cancer clinical trials improved over time? Towards bridging the gap with clinical decision making. Annals of Oncology, 18(4), 775–781.PubMedCrossRef Efficace, F., Osoba, D., Gotay, C., Sprangers, M., Coens, C., & Bottomley, A. (2007). Has the quality of health-related quality of life reporting in cancer clinical trials improved over time? Towards bridging the gap with clinical decision making. Annals of Oncology, 18(4), 775–781.PubMedCrossRef
11.
go back to reference Joly, F., Vardy, J., Pintilie, M., & Tannock, I. F. (2007). Quality of life and/or symptom control in randomized clinical trials for patients with advanced cancer. Annals of Oncology, 18, 1935–1942.PubMedCrossRef Joly, F., Vardy, J., Pintilie, M., & Tannock, I. F. (2007). Quality of life and/or symptom control in randomized clinical trials for patients with advanced cancer. Annals of Oncology, 18, 1935–1942.PubMedCrossRef
12.
go back to reference Guyatt, G. H., Naylor, C. D., Juniper, E., Heyland, D. K., Jaeschke, R., & Cook, D. J. (1997). Users’ guides to the medical literature. XII. How to use articles about health-related quality of life. Evidence-Based Medicine Working Group. Journal of the American Medical Association, 277(15), 1232–1237.PubMedCrossRef Guyatt, G. H., Naylor, C. D., Juniper, E., Heyland, D. K., Jaeschke, R., & Cook, D. J. (1997). Users’ guides to the medical literature. XII. How to use articles about health-related quality of life. Evidence-Based Medicine Working Group. Journal of the American Medical Association, 277(15), 1232–1237.PubMedCrossRef
13.
go back to reference Sprangers, M. A., Moinpour, C. M., Moynihan, T. J., Patrick, D. L., & Revicki, D. A. (2002). Assessing meaningful change in quality of life over time: A users’ guide for clinicians. Mayo Clinic Proceedings, 77(6), 561–571.PubMedCrossRef Sprangers, M. A., Moinpour, C. M., Moynihan, T. J., Patrick, D. L., & Revicki, D. A. (2002). Assessing meaningful change in quality of life over time: A users’ guide for clinicians. Mayo Clinic Proceedings, 77(6), 561–571.PubMedCrossRef
14.
go back to reference Bezjak, A., Ng, P., Skeel, R., DePetrillo, A. D., Comis, R., & Taylor, K. M. (2001). Oncologists’ use of quality of life information: Results of a survey of Eastern Cooperative Oncology Group physicians. Quality of Life Research, 10(1), 1–13.PubMedCrossRef Bezjak, A., Ng, P., Skeel, R., DePetrillo, A. D., Comis, R., & Taylor, K. M. (2001). Oncologists’ use of quality of life information: Results of a survey of Eastern Cooperative Oncology Group physicians. Quality of Life Research, 10(1), 1–13.PubMedCrossRef
15.
go back to reference Guyatt, G., & Schunemann, H. (2007). How can quality of life researchers make their work more useful to health workers and their patients? Quality of Life Research, 16, 1097–1105.PubMedCrossRef Guyatt, G., & Schunemann, H. (2007). How can quality of life researchers make their work more useful to health workers and their patients? Quality of Life Research, 16, 1097–1105.PubMedCrossRef
16.
go back to reference Brundage, M. D., Bezjak, A., Ringash, J., & Fleming, S. (2005). Patterns of reporting quality of life data in randomized clinical trials. San Francisco: ISOQOL. Ref Type: Abstract. Brundage, M. D., Bezjak, A., Ringash, J., & Fleming, S. (2005). Patterns of reporting quality of life data in randomized clinical trials. San Francisco: ISOQOL. Ref Type: Abstract.
17.
go back to reference Begg, C., Cho, M., Eastwood, S., et al. (1996). Improving the quality of reporting of randomized controlled trials. The CONSORT statement. JAMA, 276(8), 637–639.PubMedCrossRef Begg, C., Cho, M., Eastwood, S., et al. (1996). Improving the quality of reporting of randomized controlled trials. The CONSORT statement. JAMA, 276(8), 637–639.PubMedCrossRef
18.
go back to reference SAS System for Windows [computer program]. (1989). Version 6.12. Cary, NC: SAS Institute Inc. SAS System for Windows [computer program]. (1989). Version 6.12. Cary, NC: SAS Institute Inc.
19.
go back to reference Guyatt, G. H., Sackett, D. L., & Cook, D. J. (1993). Users’ guides to the medical literature. II. How to use an article about therapy or prevention. A. Are the results of the study valid? Evidence-Based Medicine Working Group. Journal of the American Medical Association, 270(21), 2598–2601.PubMedCrossRef Guyatt, G. H., Sackett, D. L., & Cook, D. J. (1993). Users’ guides to the medical literature. II. How to use an article about therapy or prevention. A. Are the results of the study valid? Evidence-Based Medicine Working Group. Journal of the American Medical Association, 270(21), 2598–2601.PubMedCrossRef
20.
go back to reference Sackett, D. L., & Cook, D. J. (1994). Users’ guides to the medical literature. II. How to use an article about therapy or prevention. B. What were the results and will they help me in caring for my patients? Evidence-Based Medicine Working Group. Journal of the American Medical Association, 271(1), 59–63.PubMedCrossRef Sackett, D. L., & Cook, D. J. (1994). Users’ guides to the medical literature. II. How to use an article about therapy or prevention. B. What were the results and will they help me in caring for my patients? Evidence-Based Medicine Working Group. Journal of the American Medical Association, 271(1), 59–63.PubMedCrossRef
21.
go back to reference Oxman, A. D., Cook, D. J., & Guyatt, G. H. (1994). Users’ guides to the medical literature. VI. How to use an overview. Evidence-Based Medicine Working Group. Journal of the American Medical Association, 272(17), 1367–1371.PubMedCrossRef Oxman, A. D., Cook, D. J., & Guyatt, G. H. (1994). Users’ guides to the medical literature. VI. How to use an overview. Evidence-Based Medicine Working Group. Journal of the American Medical Association, 272(17), 1367–1371.PubMedCrossRef
22.
go back to reference Fayers, P. M., Hopwood, P., Harvey, A., Girling, D. J., Machin, D., & Stephens, R. (1997). Quality of life assessment in clinical trials—guidelines and a checklist for protocol writers: The U.K. Medical Research Council experience. European Journal of Cancer, 33(1), 20–28.PubMedCrossRef Fayers, P. M., Hopwood, P., Harvey, A., Girling, D. J., Machin, D., & Stephens, R. (1997). Quality of life assessment in clinical trials—guidelines and a checklist for protocol writers: The U.K. Medical Research Council experience. European Journal of Cancer, 33(1), 20–28.PubMedCrossRef
23.
go back to reference Guyatt, G., Osoba, D., Wu, A., Wyrwich, K. W., & Norman, G. R. (2002). Methods to explain the clinical significance of health status measures. Mayo Clinic Proceedings, 77(4), 371–383.PubMedCrossRef Guyatt, G., Osoba, D., Wu, A., Wyrwich, K. W., & Norman, G. R. (2002). Methods to explain the clinical significance of health status measures. Mayo Clinic Proceedings, 77(4), 371–383.PubMedCrossRef
24.
25.
go back to reference Standing, L., Conezio, J., & Haber, R. (1970). Perception and memory for pictures: Single-trial learning of 2500 visual stimuli. Psychonomic Science, 19(2), 73–74. Standing, L., Conezio, J., & Haber, R. (1970). Perception and memory for pictures: Single-trial learning of 2500 visual stimuli. Psychonomic Science, 19(2), 73–74.
26.
go back to reference Feldman-Stewart, D., Kocovski, N., McConnell, B., Brundage, M., & Mackillop, W. (2000). Perception of quantitative information for treatment decisions. Medical Decision Making, 20(2), 228–238.PubMedCrossRef Feldman-Stewart, D., Kocovski, N., McConnell, B., Brundage, M., & Mackillop, W. (2000). Perception of quantitative information for treatment decisions. Medical Decision Making, 20(2), 228–238.PubMedCrossRef
27.
go back to reference Brundage, M., Feldman-Stewart, D., Leis, A., et al. (2005). Communicating quality of life information to cancer patients: A study of six presentation formats. Journal of Clinical Oncology, 23(28), 6949–6956.PubMedCrossRef Brundage, M., Feldman-Stewart, D., Leis, A., et al. (2005). Communicating quality of life information to cancer patients: A study of six presentation formats. Journal of Clinical Oncology, 23(28), 6949–6956.PubMedCrossRef
28.
go back to reference Bottomley, A., Flechtner, H., Efficace, F., et al. (2005). Health related quality of life outcomes in cancer clinical trials. [Review] [53 refs]. European Journal of Cancer, 41(12), 1697–1709.PubMedCrossRef Bottomley, A., Flechtner, H., Efficace, F., et al. (2005). Health related quality of life outcomes in cancer clinical trials. [Review] [53 refs]. European Journal of Cancer, 41(12), 1697–1709.PubMedCrossRef
Metagegevens
Titel
Patterns of reporting health-related quality of life outcomes in randomized clinical trials: implications for clinicians and quality of life researchers
Auteurs
Michael Brundage
Brenda Bass
Judith Davidson
John Queenan
Andrea Bezjak
Jolie Ringash
Anna Wilkinson
Deb Feldman-Stewart
Publicatiedatum
01-06-2011
Uitgeverij
Springer Netherlands
Gepubliceerd in
Quality of Life Research / Uitgave 5/2011
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-010-9793-3